Lysophosphatidic Acid Activates Arf6 to Promote the Mesenchymal Malignancy of Renal Cancer

Nature Communications - United Kingdom
doi 10.1038/ncomms10656
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Histone Methyltransferase MMSET/WHSC1 Activates TWIST1 to Promote an Epithelial–mesenchymal Transition and Invasive Properties of Prostate Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Lysophosphatidic Acid Receptor-Dependent Secondary Effects via Astrocytes Promote Neuronal Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

G3BP1 Activates the TGF-β/Smad Signaling Pathway to Promote Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

P2.01-24 MLPH Activates CDC42/PAK1 Signaling to Promote Epithelial–Mesenchymal Transition via TGF-β in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer

Cancers
Cancer ResearchOncology
2019English

Snail1-Driven Plasticity of Epithelial and Mesenchymal Cells Sustains Cancer Malignancy

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2015English

Elevated Plasma Levels of Lysophosphatidic Acid and Aberrant Expression of Lysophosphatidic Acid Receptors in Adenomyosis

BMC Women's Health
MedicineGynecologyReproductive MedicineObstetrics
2017English

Neurobiology of the Edg2 Lysophosphatidic Acid Receptor.

The Japanese Journal of Pharmacology
2001English

Lysophosphatidic Acid and Glutamatergic Transmission

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy